PYMNTS.com February 7, 2025

Prescription apps in the United States are experiencing growth, with the ePrescribing market expected to grow from $758.57 million in 2024 to $2.45 billion by 2030.

This progress is being driven by cost savings, improved medication adherence, and the integration of advanced technologies such as artificial intelligence and predictive analytics.

The market is becoming more competitive, as tools like telehealth become more mainstream.

PYMNTS’ Provider Ranking of Prescription Apps evaluates various apps that help users manage their medications by offering services like prescription ordering, refill reminders, drug interaction checks and pharmacy price comparisons. These apps seek to improve medication adherence and patient care, and the ranking assesses factors like user experience, reliability and feature offerings. The ranking provides insights for...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Pharma, Pharma / Biotech, Technology
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management
STAT+: Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
Roche builds in obesity with $5.3bn Zealand licensing deal
Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity
Ono pays $280M to license Ionis rare disease drug

Share This Article